Aging of platelet nitric oxide signaling: Pathogenesis, clinical implications, and therapeutics

Procter, Nathan E. K., Chong, Cher-Rin, Sverdlov, Aaron L., Chan, Wai Ping A., Chirkov, Yuliy Y. and Horowitz, John D. (2014) Aging of platelet nitric oxide signaling: Pathogenesis, clinical implications, and therapeutics. Seminars in Thrombosis and Hemostasis, 40 (6). pp. 660-668. ISSN 0094-6176

Full text not available from this repository.

Abstract

The nitric oxide (NO)/soluble guanylate cyclase (sGC) system is fundamental to endothelial control of vascular tone, but also plays a major role in the negative modulation of platelet aggregation. The phenomenon of platelet NO resistance, or decreased antiaggregatory response to NO, occurs increasingly with advanced age, as well as in the context of cardiovascular disease states such as heart failure, ischemic heart disease, and aortic valve disease. The central causes of NO resistance are “scavenging” of NO and dysfunction of sGC. In the current review, we discuss the roles of several modulators of NO synthesis and of the NO/sGC cascade on changes in platelet physiology with aging, together with potential therapeutic options to reduce associated thrombotic risk.

Item Type:	Article
Uncontrolled Keywords:	sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	LivePure Connector
Date Deposited:	19 Nov 2018 13:30
Last Modified:	21 Jun 2023 09:31
URI:	https://ueaeprints.uea.ac.uk/id/eprint/68943
DOI:	10.1055/s-0034-1389082

Actions (login required)

View Item